JDR JDR Most Cited Articles
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kikuchi, T.
Right arrow Articles by Matsuguchi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kikuchi, T.
Right arrow Articles by Matsuguchi, T.
J Dent Res 82(7): 546-550, 2003
© 2003 International and American Associations for Dental Research


RESEARCH REPORT
Biological

Cot/Tpl2 is Essential for RANKL Induction by Lipid A in Osteoblasts

T. Kikuchi1,2, Y. Yoshikai3, J. Miyoshi4, M. Katsuki5, T. Musikacharoen1, A. Mitani2, S. Tanaka2, T. Noguchi2, and T. Matsuguchi1,*

1 Laboratory of Host Defense and Germfree Life, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan;
2 Department of Periodontology, School of Dentistry, Aichi-Gakuin University, Chikusa-ku, Nagoya, Japan;
3 Research Center for Prevention of Infectious Diseases, Medical Institute of Bioregulation, Kyushu University;
4 Department of Molecular Biology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Higashinari-ku, Osaka, Japan; and
5 National Institute for Basic Biology, Okazaki, Japan;

*corresponding author, tmatsugu{at}med.nagoya-u.ac.jp

Lipopolysaccharide (LPS) is a pathogenic factor that increases bone resorption in periodontal diseases. LPS treatment of osteoblasts was shown to induce the receptor activator of NF-{kappa}B ligand (RANKL), an essential secretory or membrane-bound factor for osteoclast function, in a manner dependent on extracellular signal-regulated kinase (ERK) activation. However, the mechanisms regulating this process remained unknown. Here, we show that RANKL mRNA induction and ERK activation, when treated with synthetic lipid A (an active center of LPS), were markedly reduced in mouse osteoblasts lacking Cot/Tpl2, which was recently recognized as an essential kinase for the induction of TNF-{alpha} by LPS in macrophages. In contrast, c-Jun N-terminal kinase (JNK), p38 kinase, Raf-1, and NF-{kappa}B were normally activated in cot/tpl2-/- osteoblasts. These findings indicate that Cot/Tpl2 is essential for LPS-induced ERK activation and RANKL induction in osteoblasts.

KEY WORDS: Cot • Tpl2 • RANKL • osteoblast • lipid A




This article has been cited by other articles:


Home page
J. Dent. Res.Home page
C.S. Patil and K.L. Kirkwood
p38 MAPK Signaling in Oral-related Diseases
J. Dent. Res., September 1, 2007; 86(9): 812 - 825.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
N. Sato, N. Takahashi, K. Suda, M. Nakamura, M. Yamaki, T. Ninomiya, Y. Kobayashi, H. Takada, K. Shibata, M. Yamamoto, et al.
MyD88 But Not TRIF Is Essential for Osteoclastogenesis Induced by Lipopolysaccharide, Diacyl Lipopeptide, and IL-1{alpha}
J. Exp. Med., September 7, 2004; 200(5): 601 - 611.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2003 Institutional Access Guidelines